'Site-less' tri­als in mind, No­var­tis launch­es an app for oph­thal­mol­o­gy re­search

In the lat­est com­pa­ny move to em­brace all things dig­i­tal, No­var­tis has launched an app that it hopes will boost par­tic­i­pa­tion in its oph­thal­mol­o­gy tri­als.

The phar­ma gi­ant is call­ing the tech Fo­calView, and it’ll be used by re­searchers to track dis­ease pro­gres­sion in pa­tients with oph­thalmic dis­ease re­al-time. Pa­tients will self-re­port da­ta through the app that will guide clin­i­cal re­search, start­ing by tak­ing as­sess­ments like vi­su­al acu­ity and con­trast sen­si­tiv­i­ty tests.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.